Summary

The global market for Ventricular Septal Defect (VSD) Occluder was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
North American market for Ventricular Septal Defect (VSD) Occluder was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ventricular Septal Defect (VSD) Occluder was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Ventricular Septal Defect (VSD) Occluder was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Ventricular Septal Defect (VSD) Occluder include Abbott, Occlutech, Lepu Medical Technology(Beijing), MicroPort Group, Meril Life, Vascular Innovations, Lifetech, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Ventricular Septal Defect (VSD) Occluder, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ventricular Septal Defect (VSD) Occluder by region & country, by Type, and by Application.

The Ventricular Septal Defect (VSD) Occluder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ventricular Septal Defect (VSD) Occluder.

Market Segmentation
By Company
Abbott
Occlutech
Lepu Medical Technology(Beijing)
MicroPort Group
Meril Life
Vascular Innovations
Lifetech
Segment by Type
Membranous Type
Muscular Type
Segment by Application
Infant
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ventricular Septal Defect (VSD) Occluder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ventricular Septal Defect (VSD) Occluder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ventricular Septal Defect (VSD) Occluder in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Ventricular Septal Defect (VSD) Occluder Product Introduction
1.2 Global Ventricular Septal Defect (VSD) Occluder Market Size Forecast
1.2.1 Global Ventricular Septal Defect (VSD) Occluder Sales Value (2020-2031)
1.2.2 Global Ventricular Septal Defect (VSD) Occluder Sales Volume (2020-2031)
1.2.3 Global Ventricular Septal Defect (VSD) Occluder Sales Price (2020-2031)
1.3 Ventricular Septal Defect (VSD) Occluder Market Trends & Drivers
1.3.1 Ventricular Septal Defect (VSD) Occluder Industry Trends
1.3.2 Ventricular Septal Defect (VSD) Occluder Market Drivers & Opportunity
1.3.3 Ventricular Septal Defect (VSD) Occluder Market Challenges
1.3.4 Ventricular Septal Defect (VSD) Occluder Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ventricular Septal Defect (VSD) Occluder Players Revenue Ranking (2024)
2.2 Global Ventricular Septal Defect (VSD) Occluder Revenue by Company (2020-2025)
2.3 Global Ventricular Septal Defect (VSD) Occluder Players Sales Volume Ranking (2024)
2.4 Global Ventricular Septal Defect (VSD) Occluder Sales Volume by Company Players (2020-2025)
2.5 Global Ventricular Septal Defect (VSD) Occluder Average Price by Company (2020-2025)
2.6 Key Manufacturers Ventricular Septal Defect (VSD) Occluder Manufacturing Base and Headquarters
2.7 Key Manufacturers Ventricular Septal Defect (VSD) Occluder Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ventricular Septal Defect (VSD) Occluder
2.9 Ventricular Septal Defect (VSD) Occluder Market Competitive Analysis
2.9.1 Ventricular Septal Defect (VSD) Occluder Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Ventricular Septal Defect (VSD) Occluder Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ventricular Septal Defect (VSD) Occluder as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Membranous Type
3.1.2 Muscular Type
3.2 Global Ventricular Septal Defect (VSD) Occluder Sales Value by Type
3.2.1 Global Ventricular Septal Defect (VSD) Occluder Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Ventricular Septal Defect (VSD) Occluder Sales Value, by Type (2020-2031)
3.2.3 Global Ventricular Septal Defect (VSD) Occluder Sales Value, by Type (%) (2020-2031)
3.3 Global Ventricular Septal Defect (VSD) Occluder Sales Volume by Type
3.3.1 Global Ventricular Septal Defect (VSD) Occluder Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Ventricular Septal Defect (VSD) Occluder Sales Volume, by Type (2020-2031)
3.3.3 Global Ventricular Septal Defect (VSD) Occluder Sales Volume, by Type (%) (2020-2031)
3.4 Global Ventricular Septal Defect (VSD) Occluder Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Infant
4.1.2 Other
4.2 Global Ventricular Septal Defect (VSD) Occluder Sales Value by Application
4.2.1 Global Ventricular Septal Defect (VSD) Occluder Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Ventricular Septal Defect (VSD) Occluder Sales Value, by Application (2020-2031)
4.2.3 Global Ventricular Septal Defect (VSD) Occluder Sales Value, by Application (%) (2020-2031)
4.3 Global Ventricular Septal Defect (VSD) Occluder Sales Volume by Application
4.3.1 Global Ventricular Septal Defect (VSD) Occluder Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Ventricular Septal Defect (VSD) Occluder Sales Volume, by Application (2020-2031)
4.3.3 Global Ventricular Septal Defect (VSD) Occluder Sales Volume, by Application (%) (2020-2031)
4.4 Global Ventricular Septal Defect (VSD) Occluder Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Ventricular Septal Defect (VSD) Occluder Sales Value by Region
5.1.1 Global Ventricular Septal Defect (VSD) Occluder Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Ventricular Septal Defect (VSD) Occluder Sales Value by Region (2020-2025)
5.1.3 Global Ventricular Septal Defect (VSD) Occluder Sales Value by Region (2026-2031)
5.1.4 Global Ventricular Septal Defect (VSD) Occluder Sales Value by Region (%), (2020-2031)
5.2 Global Ventricular Septal Defect (VSD) Occluder Sales Volume by Region
5.2.1 Global Ventricular Septal Defect (VSD) Occluder Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Ventricular Septal Defect (VSD) Occluder Sales Volume by Region (2020-2025)
5.2.3 Global Ventricular Septal Defect (VSD) Occluder Sales Volume by Region (2026-2031)
5.2.4 Global Ventricular Septal Defect (VSD) Occluder Sales Volume by Region (%), (2020-2031)
5.3 Global Ventricular Septal Defect (VSD) Occluder Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
5.4.2 North America Ventricular Septal Defect (VSD) Occluder Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
5.5.2 Europe Ventricular Septal Defect (VSD) Occluder Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
5.6.2 Asia Pacific Ventricular Septal Defect (VSD) Occluder Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
5.7.2 South America Ventricular Septal Defect (VSD) Occluder Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
5.8.2 Middle East & Africa Ventricular Septal Defect (VSD) Occluder Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ventricular Septal Defect (VSD) Occluder Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Ventricular Septal Defect (VSD) Occluder Sales Value
6.2.1 Key Countries/Regions Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
6.2.2 Key Countries/Regions Ventricular Septal Defect (VSD) Occluder Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
6.3.2 United States Ventricular Septal Defect (VSD) Occluder Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Ventricular Septal Defect (VSD) Occluder Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
6.4.2 Europe Ventricular Septal Defect (VSD) Occluder Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Ventricular Septal Defect (VSD) Occluder Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
6.5.2 China Ventricular Septal Defect (VSD) Occluder Sales Value by Type (%), 2024 VS 2031
6.5.3 China Ventricular Septal Defect (VSD) Occluder Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
6.6.2 Japan Ventricular Septal Defect (VSD) Occluder Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Ventricular Septal Defect (VSD) Occluder Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
6.7.2 South Korea Ventricular Septal Defect (VSD) Occluder Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Ventricular Septal Defect (VSD) Occluder Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
6.8.2 Southeast Asia Ventricular Septal Defect (VSD) Occluder Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Ventricular Septal Defect (VSD) Occluder Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Ventricular Septal Defect (VSD) Occluder Sales Value, 2020-2031
6.9.2 India Ventricular Septal Defect (VSD) Occluder Sales Value by Type (%), 2024 VS 2031
6.9.3 India Ventricular Septal Defect (VSD) Occluder Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Ventricular Septal Defect (VSD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Abbott Ventricular Septal Defect (VSD) Occluder Product Offerings
7.1.5 Abbott Recent Development
7.2 Occlutech
7.2.1 Occlutech Company Information
7.2.2 Occlutech Introduction and Business Overview
7.2.3 Occlutech Ventricular Septal Defect (VSD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Occlutech Ventricular Septal Defect (VSD) Occluder Product Offerings
7.2.5 Occlutech Recent Development
7.3 Lepu Medical Technology(Beijing)
7.3.1 Lepu Medical Technology(Beijing) Company Information
7.3.2 Lepu Medical Technology(Beijing) Introduction and Business Overview
7.3.3 Lepu Medical Technology(Beijing) Ventricular Septal Defect (VSD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Lepu Medical Technology(Beijing) Ventricular Septal Defect (VSD) Occluder Product Offerings
7.3.5 Lepu Medical Technology(Beijing) Recent Development
7.4 MicroPort Group
7.4.1 MicroPort Group Company Information
7.4.2 MicroPort Group Introduction and Business Overview
7.4.3 MicroPort Group Ventricular Septal Defect (VSD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 MicroPort Group Ventricular Septal Defect (VSD) Occluder Product Offerings
7.4.5 MicroPort Group Recent Development
7.5 Meril Life
7.5.1 Meril Life Company Information
7.5.2 Meril Life Introduction and Business Overview
7.5.3 Meril Life Ventricular Septal Defect (VSD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Meril Life Ventricular Septal Defect (VSD) Occluder Product Offerings
7.5.5 Meril Life Recent Development
7.6 Vascular Innovations
7.6.1 Vascular Innovations Company Information
7.6.2 Vascular Innovations Introduction and Business Overview
7.6.3 Vascular Innovations Ventricular Septal Defect (VSD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Vascular Innovations Ventricular Septal Defect (VSD) Occluder Product Offerings
7.6.5 Vascular Innovations Recent Development
7.7 Lifetech
7.7.1 Lifetech Company Information
7.7.2 Lifetech Introduction and Business Overview
7.7.3 Lifetech Ventricular Septal Defect (VSD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Lifetech Ventricular Septal Defect (VSD) Occluder Product Offerings
7.7.5 Lifetech Recent Development
8 Industry Chain Analysis
8.1 Ventricular Septal Defect (VSD) Occluder Industrial Chain
8.2 Ventricular Septal Defect (VSD) Occluder Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ventricular Septal Defect (VSD) Occluder Sales Model
8.5.2 Sales Channel
8.5.3 Ventricular Septal Defect (VSD) Occluder Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer